141 related articles for article (PubMed ID: 35617592)
21. Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation.
Jackevicius CA; Lu L; Ghaznavi Z; Warner AL
Circ Cardiovasc Qual Outcomes; 2021 Feb; 14(2):e007230. PubMed ID: 33541109
[TBL] [Abstract][Full Text] [Related]
22. Real-World Adherence and Persistence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Ozaki AF; Choi AS; Le QT; Ko DT; Han JK; Park SS; Jackevicius CA
Circ Cardiovasc Qual Outcomes; 2020 Mar; 13(3):e005969. PubMed ID: 32148102
[TBL] [Abstract][Full Text] [Related]
23. Switching to Another Oral Anticoagulant and Drug Discontinuation Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Different Direct Oral Anticoagulants.
Baker CL; Dhamane AD; Rajpura J; Mardekian J; Dina O; Russ C; Rosenblatt L; Lingohr-Smith M; Lin J
Clin Appl Thromb Hemost; 2019; 25():1076029619870249. PubMed ID: 31418293
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy.
Barra ME; Fanikos J; Connors JM; Sylvester KW; Piazza G; Goldhaber SZ
Am J Med; 2016 Nov; 129(11):1198-1204. PubMed ID: 27341955
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Extreme Obesity.
Russo V; Cattaneo D; Giannetti L; Bottino R; Laezza N; Atripaldi U; Clementi E
Clin Ther; 2021 Sep; 43(9):e255-e263. PubMed ID: 34366151
[TBL] [Abstract][Full Text] [Related]
26. Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulants.
Testa S; Paoletti O; Legnani C; Dellanoce C; Antonucci E; Cosmi B; Pengo V; Poli D; Morandini R; Testa R; Tripodi A; Palareti G
J Thromb Haemost; 2018 May; 16(5):842-848. PubMed ID: 29532628
[TBL] [Abstract][Full Text] [Related]
27. Non-Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction.
Yao X; Shah ND; Sangaralingham LR; Gersh BJ; Noseworthy PA
J Am Coll Cardiol; 2017 Jun; 69(23):2779-2790. PubMed ID: 28595692
[TBL] [Abstract][Full Text] [Related]
28. Trends in anticoagulant prescribing: a review of local policies in English primary care.
Ho KH; van Hove M; Leng G
BMC Health Serv Res; 2020 Apr; 20(1):279. PubMed ID: 32245380
[TBL] [Abstract][Full Text] [Related]
29. The problem of underdosing with direct-acting oral anticoagulants in elderly patients with nonvalvular atrial fibrillation.
Fernández CS; Gullón A; Formiga F
J Comp Eff Res; 2020 May; 9(7):509-523. PubMed ID: 32329353
[TBL] [Abstract][Full Text] [Related]
30. Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants.
Camm AJ; Cools F; Virdone S; Bassand JP; Fitzmaurice DA; Arthur Fox KA; Goldhaber SZ; Goto S; Haas S; Mantovani LG; Kayani G; Grierson Turpie AG; Antoon Verheugt FW; Kakkar AK;
J Am Coll Cardiol; 2020 Sep; 76(12):1425-1436. PubMed ID: 32943160
[TBL] [Abstract][Full Text] [Related]
31. Appropriateness of the Direct Oral Anticoagulants Dosing in the Middle East Gulf Region.
Anouassi Z; Atallah B; Alsoud LO; El Nekidy W; Al Mahmeed W; AlJaabari M; Almuti K
J Cardiovasc Pharmacol; 2021 Feb; 77(2):182-188. PubMed ID: 32925474
[TBL] [Abstract][Full Text] [Related]
32. [Oral anticoagulation in atrial fibrillation: What is the guideline for using new drugs?].
Ibáñez Pérez de Viñaspre JA; Gómez Bitrian J; Royo Hernández R; de Azúa Jiménez M; Marco López C; Urieta González L
Semergen; 2018; 44(5):297-303. PubMed ID: 28867369
[TBL] [Abstract][Full Text] [Related]
33. Impact of the COVID-19 pandemic on England's national prescriptions of oral vitamin K antagonist (VKA) and direct-acting oral anticoagulants (DOACs): an interrupted time series analysis (January 2019-February 2021).
Alkhameys S; Barrett R
Curr Med Res Opin; 2022 Jul; 38(7):1081-1092. PubMed ID: 35582854
[TBL] [Abstract][Full Text] [Related]
34. Inappropriate dosing of direct oral anticoagulants in patients with atrial fibrillation.
Lavoie K; Turgeon MH; Brais C; Larochelle J; Blais L; Farand P; Letemplier G; Perreault S; Beauchesne MF
J Atr Fibrillation; 2016 Dec; 9(4):1478. PubMed ID: 29250254
[TBL] [Abstract][Full Text] [Related]
35. Apixaban for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: The PAROS cross-sectional study of routine clinical practice.
Falissard B; Picard F; Mahe I; Hanon O; Touzé E; Danchin N; Lamy FX; Ricci L; Steg PG
Arch Cardiovasc Dis; 2019; 112(6-7):400-409. PubMed ID: 31014991
[TBL] [Abstract][Full Text] [Related]
36. Modification of In-Hospital Recommendation and Prescription of Anticoagulants for Secondary Prevention of Stroke after Launch of Direct Oral Anticoagulants and Change of National Guidelines.
Gronemann C; Hause S; Assmann A; Neumann J; Schreiber S; Heinze HJ; Goertler M
Cerebrovasc Dis; 2020; 49(4):412-418. PubMed ID: 32756054
[TBL] [Abstract][Full Text] [Related]
37. Impact of non-adherence to direct oral anticoagulants amongst Swedish patients with non-valvular atrial fibrillation: results from a real-world cost-utility analysis.
Blomström Lundqvist C; Själander S; Garcia Rodriguez LA; Åkerborg Ö; Jin G; Caleyachetty A; Huelsebeck M; Bowrin K; Schaefer B; Mahdessian H; Hofmeister L; Levin LÅ
J Med Econ; 2022; 25(1):1085-1091. PubMed ID: 35997241
[TBL] [Abstract][Full Text] [Related]
38. Analysis of Oral Anticoagulant Dosing and Adherence to Therapy Among Patients With Nonvalvular Atrial Fibrillation.
Rymer JA; Chiswell K; Young L; Chiu A; Liu L; Webb L; Carlisle M; Friedman D; Wang TY
JAMA Netw Open; 2023 Jun; 6(6):e2317156. PubMed ID: 37285155
[TBL] [Abstract][Full Text] [Related]
39. Appropriateness of direct oral anticoagulant prescribing in older subjects with atrial fibrillation discharged from acute medical wards.
De Vincentis A; Soraci L; Arena E; Sciacqua A; Armentaro G; Aucella F; Corsonello A; Aucella F; Antonelli Incalzi R
Br J Clin Pharmacol; 2024 May; 90(5):1231-1239. PubMed ID: 38321367
[TBL] [Abstract][Full Text] [Related]
40. Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients With Atrial Fibrillation in the United States.
Sandhu A; Kaltenbach LA; Chiswell K; Shimoga V; Ashur C; Pribish A; Fonarow GC; Piccini JP; Ho PM; Varosy PD; Hess PL
Circ Cardiovasc Qual Outcomes; 2023 Dec; 16(12):e010062. PubMed ID: 37929603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
